Bi-source green, such as weight loss drugs are referred to as health food effect of basic by blowing

In all areas of treatment, the market for weight loss (lose weight) has almost no suspense to have the most active patient needs, when lighter, thinner not only become a health demand, but also become more and more common aesthetic standards, drugs and health care market also eager. While the global drug watchdog has been tightening its approval for weight-loss drugs for security reasons, the drug market, which is trying to beat the ball, is almost insane. Thus, in the weight loss "drug 国药准字" products collectively fall, health food has become a weight loss market, "the force." In addition, some of the various weight loss products are also beginning to flood a variety of marketing channels. Previously, the National Drug Administration has exposed "7 color thin", "slimming slimming capsules" and other 21 counterfeit health food, of which 13 belong to weight loss category, the detection of sibutramine and laxatives phenolphthalein. Some weight loss products have also been illegally added ephedrine, amphetamine or diuretic ingredients. Experts also pointed out that, such as green thin, bi-carnitine, L-carnitine and other related foreign claims to weight loss drug products, its essence belongs to the category of health food. "Empty Window" of the Regular army "drug 国药准字" weight loss products empty window period has lasted 3 years. Since 2000, sibutramine hydrochloride (trimebutine) in China to be listed, to October 31, 2010 Because of security issues by the State administration of medicine emergency stop, to the famous "Qu Mei" as a typical representative of the "drug 国药准字" weight loss products in the Chinese market has experienced a real "golden decade." "Trimebutine after we have seen other varieties, want to borrow the original channel to make up for the loss, but can not find similar products, the difference is too much." "Yesterday, Trimebutine, a large national distributor of the first financial daily interview, said," the product itself, it is difficult to have a company to invest in a single species of huge efforts to nurture, and I am afraid it is difficult to meet. "1997, the United States Abbott pharmaceutical to sibutramine hydrochloride as the main ingredient of the central weight loss drug obtained FDA approved the listing; 2000, Sichuan Taiji pharmaceutical imitation species" Qu Mei "in the domestic market, in the latter intensive advertising marketing promotion, Trimebutine sales quickly released, become the domestic market share the biggest winner. According to the National Food and Drug Administration Southern Medicine and Economic Research Institute (SFDA south) Guangzhou Punctuation Medicine Information Co., Ltd. data, 2009 domestic diet Medicine (prescription drugs) market scale of 1.09 billion yuan, and the song US single varieties of sales reached 897 million yuan, the average annual market share of 76.3%. This point from the Tai Chi Group (9.49,-0.17,-1.76%) public information can also be confirmed that the listing within 10 years, trimebutine a total of 5 billion yuan sales revenue, the highest annual sales of 400 million yuan. Even in the first half of the year, the "Qu Mei" as the representative of the capsule agent only 15.15 million yuan cost to change back to 123 million yuan income, the profit rate of up to 87.64%, belong to the absolute star products. The turning point of the great and bad transition takes place in 2010 years. Because the long-term use of central type weight loss drugs will cause the heart and nervous system, etc.Reports of serious damage has increased, the European Union, the United States has announced the delisting of sibutramine hydrochloride, in October, China's Drug Supervision Bureau also finally announced the Trimebutine and other representative varieties of the next frame. "Academia has been more cautious about drug-loss, doctors generally do not take the initiative to prescribe such drugs to patients, even if it is really necessary, the drug must only be a supporting role," The National Drug Evaluation Center expert Sun Zhongxi on this issue, said, "The international has approved a total of 6 weight loss drugs, Now 5 have been stopped because of security problems. "The only surviving is Oliver." and trimebutine used to inhibit appetite in the central nervous mechanism, peripheral weight loss medicine Oliver He by blocking the food in the fat hydrolysis, reduce the body's calorie intake, once became a clinician recognized safer weight loss products. "Oliver he sells very well in the white-collar crowd in big cities, although it was sold trimebutine, but the market has been stable." The distributor told the newspaper. As a weight-loss drug developed by the Swiss Roche Company, Orlistat (Chinese commodity Name "Saini") has brought hundreds of billions of dollars of sales to Roche every year, so far the global sales of more than 5 billion Swiss francs have been accumulated. The figures show that Roche has more than 300 million dollars a year in the global campaign, and that in China, more than 50% of the Saini can be used in hospitals, mainly in the form of academic meetings and the establishment of obesity clinics. But 2010, Trimebutine should vacate the market space and did not give Saini can bring too long joy, a paper safety notice will Saini can also push into the market downward cycle. March 4, 2011, the National Drug Administration website released "State Food and Drug Administration to remind him of safety issues" notice: Announced as at December 31, 2010, a total of 120 cases of his case reported, the main adverse reactions are constipation, abdominal pain, diarrhea, dizziness, Menstrual disorders, rashes, and some rare allergic reactions. In combination with the FDA's warning that it could cause serious liver damage, and Roche's subsequent stripping of over-the-counter markets, Saini's sales in China are slipping until it finally disappears completely from the market. Although in April 2011, the Chongqing plant Grace of Oliver, his imitation "Ya-plastic" after the market after the only batch of over-the-counter drug products, but because of the safety of many products previously caused by the loss of confidence, as well as marketing input and other issues, has not been able to form a dominant position in the market. "Strong demand, great business opportunities, too little or no sufficient market competition," Zhang Jiming, chief consultant of Shanghai Sandy Marketing advisory Body, said to this newspaper, "This market size and prospects are very large, but the need for sustained input and accurate positioning, but also with various types of health products to distinguish competition. "Crazy edge" health care products are better to do is, advertising effective quickly, and the consumer's mentality is that this kind of thing is not medicine, safety, spending is not much. Yesterday, the head of a platform medicine electricity company told this newspaper. Public numberIt has been shown that China's weight loss market is growing at a geometric level, obese patients have more than 90 million, weight loss products to the annual increase of 20%, the total annual sales can reach tens of billions of dollars. The official told reporters, in their shop, into the May, slimming health care products, tea and other category sales rose significantly, "tea products have been very stable, a few brands are good." "he told reporters. Although he did not further disclose the specific category of sales growth, but in the Diet tea drink market ranking has been relatively stable. 2010, the main business for health tea Green Source (00926.HK) landed in Hong Kong SEHK. According to the official research report published by the company when the company was listed, the 2008-2009-year retail sales account has been the largest raw material purchaser and the largest supplier of health tea in China's health tea market, with a market share of 18.8% last year and a second only 5.5%. In the 2007-2009 and two years, the composite annual growth rate and the net profit growth rate of the bi-income students reached 99.1% and 72.5% respectively. According to the public data, the 2009, the bi-source Chang and bi-students slimming tea Two products sales revenue accounted for 98.8% of the total turnover. In fact, the green source in the prospectus: the provincial Food and Drug Administration website shows that in the past three years a total of 23 public warnings, involving misleading advertising, false ingredients, or improper use of the name of the portrait, and the lack of timely access to permits. The latest is the Guangdong Food and Drug Administration issued by the Guangdong Province in 2009, the fifth issue of illegal health food Advertising bulletin, the source for "exaggerated product indications, functional indications or contain unscientific expression of efficacy assertion, guarantee" and the list. In the prospectus, the company admitted: "In the past, some of the group's product advertisements or related propaganda practices have not fully complied with the relevant regulations, and the relevant government departments have imposed fines on these incidents." And in the "Big Impression diet Tea" website that claims to "drink a good figure," product description of a, its confirmation is to "tea, Gynostemma pentaphyllum, abalone, mangosteen, Senna, honeysuckle as the main raw materials made of health food", but also High-profile said, "The functional test proved that with weight loss, regulating blood lipids" Medical care function. Bi-students repeatedly hit the line of false propaganda, in the field of health care products marketing is even necessary to do "homework." "Health care products in sales, marketing can account for almost 60% or even 70% of the cost, we fight is advertising, who can more than rivals to bomb the ears and eyes of consumers, who accounted for more market." Yesterday, an unnamed health care product brand marketing director told the newspaper, "essentially products no difference, no technical content, is relying on advertising, find selling points." "Tomson Times Jian (300146.SZ) Slim slender capsule (national food Health word) is known as" the State Food and Drug Administration approved, with weight loss, enhance the immunity of the dual health function ", at the same time" effective decomposition of the waist, abdomen, buttocks and other parts of the accumulation of fat, directional liposuction oil discharge, concentrated fiber waist thin abdomen, the sculpture curve. " Tomson Times Health 2012 annual report showed that year's sales cost nearly 266 million yuan, an increase of 47%, "mainly sales force expansion and increased brand investment lead." The 2012 annual report showed that 2012 sales revenue of 475 million yuan, down 43% year-on-year, and advertising and marketing expenditure of 563 million yuan, of which advertising expenditure reached 312 million yuan, accounting for the income of 65.6%. According to the public information, big impression weight loss tea advertising costs in 2006 has reached 150 million yuan. The data published by the State administration of drugs and Drug Administration show: in the survey of 176 health-care products stores found that more than 96% of the products store sales of drugs are not drug posing as drug sales, in 6 provinces, 1253 retail pharmacies found that the drug product sales accounted for about the total pharmacy sales of 10%, And the trend is rising yearly. "Health food is not a drug and cannot claim therapeutic efficacy." Some illegal health food ads tend to exaggerate product effectiveness, contain absolute terms and false promises, claiming to be able to treat a disease, or "non-toxic side effects," and other commitments to seriously deceive, induce consumers. May 24, the State administration of Food and Drug Administration spokesman Jiangying in health food hit "Four Non" (illegal production, illegal operation, illegal addition, illegal publicity) Situation press conference, again stressed that "health food is not a drug, no therapeutic effect." ”